bit.bio Secures Major Patent Victory for Revolutionary opti-ox™ Cell Programming Technology
bit.bio has successfully defended its European patent for the groundbreaking opti-ox™ technology, which facilitates the precise programming of pluripotent stem cells (PSCs), including induced pluripotent stem cells (iPSCs), into any…
Marinus Pharmaceuticals Expands Intellectual Property with New Patent for ZTALMY® Titration Methods
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a company focused on developing innovative treatments for seizure disorders, announced the addition of a new patent to its intellectual property portfolio. The United States…
Anthem Blue Cross and Open Table Launch Initiative to Tackle Youth Substance Use Disorder
As part of a three-year, $30 million initiative focused on mental health and well-being, the Anthem Blue Cross and Blue Shield Foundation has launched a new program in Shenandoah County,…
UroGen Announces FDA Acceptance of New Drug Application for UGN-102
PDUFA Goal Date Set for June 13, 2025: UGN-102 Could Be First FDA-Approved Treatment for LG-IR-NMIBC UroGen Pharma Ltd. (Nasdaq: URGN), a biotechnology company committed to developing innovative solutions for…
FDA Approves Novocure’s Optune Lua® for Metastatic Non-Small Cell Lung Cancer Treatment
FDA Approves Optune Lua® as First-of-its-Kind Treatment for Metastatic Non-Small Cell Lung Cancer Novocure (NASDAQ: NVCR) announced that the U.S. Food and Drug Administration (FDA) has approved Optune Lua®, a…
Lenovo Launches First AI Avatar for Alzheimer’s and Dementia Care
At Lenovo Tech World, Lenovo™, in collaboration with Innovations in Dementia, launched “Alzheimer’s Intelligence,” a photorealistic 3D avatar powered by AI, designed to support individuals and families affected by dementia…
FDA Clears SPECTRALIS Flex Module, Enhancing Advanced Ophthalmic Imaging for Underserved Patients
Heidelberg Engineering, a leading provider of ophthalmic imaging and healthcare data solutions, has announced that the FDA has granted clearance for its SPECTRALIS® Flex Module. This advanced, multimodal imaging platform…
Bausch + Lomb Gains FDA Approval for enVista Envy Intraocular Lens Offering Full Range of Vision
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a global leader in eye health, has announced that the U.S. Food and Drug Administration has approved the enVista® Envy™ intraocular lens (IOL). This…
Supergut Expands Nationwide at Target Amid Sales Surge
Supergut, the first clinically validated nutrition brand for gut health, is now available at Target stores across the U.S. and online at Target.com. The brand’s exclusive Target lineup features its…
MEDiC Life Sciences Partners with Hanmi on Cancer Biomarker Discovery, Secures Strategic Investment
MEDiC Life Sciences, a biotech startup based in Silicon Valley, has announced a new research collaboration with Hanmi Pharmaceutical, a prominent biopharmaceutical company in Korea. The partnership aims to identify…
Biogen’s Felzartamab Gains FDA Breakthrough Therapy Designation for Kidney Transplant Rejection
Biogen Inc. (Nasdaq: BIIB) – Biogen announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to felzartamab, an investigational anti-CD38 monoclonal antibody. This…
GSK Reports Positive Data for Arexvy RSV Vaccine, Showing Protection Over Three Seasons
GSK plc (LSE/NYSE: GSK) has announced new findings from the AReSVi-006 Phase III trial, which assessed the effectiveness of a single dose of Arexvy, a recombinant adjuvanted vaccine for respiratory…